41 In patients with overweight or obesity without diabetes, the SURMOUNT-1 trial showed that tirzepatide 15 mg weekly led to a mean body weight reduction of 20.9% after 72 weeks of treatment, compared with 3.1% with placebo
Writing in an editorial for PLOS Mental Health, she also recommends exploring other options when possible so that people in crisis can stay at home with their families monitoring them and with a providers support
For back pain, certain peptides target areas like muscles, tendons, and even spinal discs, helping to reduce swelling and promote healing where you need it most
Lemas, PhD, assistant professor in the department of health outcomes and biomedical informatics, and faculty member at the Institute for Child Health Policy at University of Florida College of Medicine, said the FDA currently recommends that women stop using GLP-1s at least 2 months before conception due to fetal toxicity that was observed in some animal studies
Consider Retatrutide If: Maximum weight loss represents your overriding goal